Strengthened profitability and cash flow despite a quarter with macro headwinds. In the third quarter, organic sales decreased by 4.8% in constant currency, but the year-to-date growth remains positive. The work on operational efficiency is having an effect and EBITA increased by SEK 1.0 million while the EBITA margin amounted to 15.5% (13.7%). Cash flow … Read more
The third quarter of 2024 showed strong order intake, +17%, and net revenue growth, +26%. Despite challenging comparative figures from 2023, especially in the pharmaceutical sector and rental of equipment for clinical trials, we showed robust development. Excluding these segments, we saw organic growth of 6% for January−September, reflecting the strength of our business. July–September … Read more
July-September 2023 Net revenue for the period was SEK 321.1 million (237.0), an increase of 35.5%. Organic growth was 18.0%. Orders received for the period was SEK 360.0 million (268.4), an increase of 34.1%. Organic growth was 30.1%. EBITDA for the period was SEK 93.6 million (39.2) Profit/loss for the period was SEK 34.8 million … Read more
July-September 2022 Net revenue for the period was SEK 237.0 million (105.6), an increase of 124.5 %. Organic growth was 27.2 %. Orders received for the period was SEK 268.4 million (107.1), an increase of 150.7 %. Organic growth was 20.6 %. Adjusted EBITDA for the period was SEK 36.0 million (14.5) EBITDA for the … Read more
July – September 2021 Net revenue for the period was SEK 105.6 million (76.2), an increase of 38.6 %. Organic growth was 12.1 %. Adjusted EBITDA for the period was SEK 14.5 million (5.3) EBITDA for the period was SEK 13.3 million (9.4) Adjusted profit/loss for the period was SEK 3.0 million (-1.2) Basic earnings … Read more